The FDA has given Amgen (AMGN) the green light to bring its breakthrough lung cancer drug Lumakras to the market. Amgen is a …
Amgen has agreed to snap up clinical-stage biotech Five Prime Therapeutics for an equity value of $1.9 billion, to strengthen the company’s oncology …
Amgen announced on Jan. 29 that its experimental lung cancer drug, sotorasib, had been granted “Breakthrough Therapy Designation (BTD)” by the Center for …
Amgen (AMGN) and AstraZeneca (AZN) have announced positive topline results from the Phase 3 Navigator trial for tezepelumab, which demonstrated a statistically significant …
Amgen Inc.’ 3Q revenues jumped 12% to $6.
Amgen (AMGN) has announced an additional investment of approximately $421 million in BeiGene’s (BGNE) registered direct offering of ordinary shares. This investment maintains Amgen’s current …
Amgen, Inc. (NASDAQ:AMGN) shares are falling nearly 10% in Friday’s trading session, leaving investors scratching their heads after the biotech giant actually reported above consensus third-quarter revenues …
There are many things that cause a stock to move: acquisition rumors, news stories (both positive and negative), earnings releases, analyst upgrades/downgrades, ETF-forced …
This Weekend my eyes and thoughts curved around the Healthcare sector. I read several interesting articles from the sector, mostly about the biotech’s …
The stock market isn’t providing good discounts especially in quality names, but at least the return of volatility is providing some opportunities for …